Suzhen Xu Selected Research

ganoderic acid D

1/2022

Sporoderm-Broken Spores of Ganoderma lucidum Sensitizes Ovarian Cancer to Cisplatin by ROS/ERK Signaling and Attenuates Chemotherapy-Related Toxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suzhen Xu Research Topics

Disease

2	Neoplasms (Cancer) 01/2022 - 11/2017
1	Cough 01/2022
1	Exanthema (Rash) 01/2022
1	Fever (Fevers) 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Epstein-Barr Virus Infections 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Disease Progression 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Adenocarcinoma 01/2018
1	Pain (Aches) 10/2013

Drug/Important Bio-Agent (IBA)

1	PlatinumIBA 01/2022
1	Transaminases (Aminotransferases)IBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	EnzymesIBA 01/2022
1	ganoderic acid DIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 11/2017
1	Messenger RNA (mRNA)IBA 11/2017
1	lornoxicamIBA 10/2013

Therapy/Procedure

1	Therapeutics 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Prostatectomy (Retropubic Prostatectomy) 01/2019
1	Immunotherapy 01/2018